- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02898818
Vaginal and Oral Microbiome Crosstalk
December 22, 2023 updated by: Turku University Hospital
EMMI - Emättimen Mikrobiomi - Emättimen ja Suun Limakalvojen Vuorovaikutus
To study the vaginal and oral microbiome by swab samples.
On selected cases, also papa smear will be studied.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
To study the vaginal and oral microbiome by swab samples and on selected groups, by papa smear test, to find out the constitution of normal and vaginal microbiome and the cross-talk between oral and vaginal mucosa.
To find out about the impact of human papilloma virus on the microbiome and vice versa.
Study Type
Observational
Enrollment (Estimated)
520
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Niina K Hieta, MD, PhD
- Phone Number: +358- 2-3131620
- Email: niina.hieta@tyks.fi
Study Contact Backup
- Name: Katja M Kero, MD, PhD
- Phone Number: +358- 2-3130000
- Email: katja.kero@tyks.fi
Study Locations
-
-
-
Turku, Finland, 20540
- Recruiting
- Turku University Hospital
-
Contact:
- Niina K Hieta, MD, PhD
- Phone Number: +358- 2-3131620
- Email: niina.hieta@tyks.fi
-
Contact:
- Katja M Kero, MD, PhD
- Phone Number: +358- 2-3130000
- Email: katja.kero@tyks.fi
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Patients coming to Turku University Hospital Dermato-Venereology Department for venereal disease tests with or without vaginal discharge.
Patients coming to Turku University Hospital Gynaecology Department by remission because of atypical papa smear test result or (controls) for some other reason
Description
Inclusion Criteria:
- patients coming to Turku University Hospital Dermato-Venereology or Gynaecology Departments for previously mentioned reasons
Exclusion Criteria:
- those not meeting the criteria
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Other
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
symptomless
vaginal and oral swab sample, questionnaire
|
vaginal and oral swab sample and questionnaire
|
vaginal discharge
vaginal and oral swab sample, questionnaire
|
vaginal and oral swab sample and questionnaire
|
atypical papa smear
vaginal and oral swab sample, questionnaire, papa smear
|
vaginal and oral swab sample and questionnaire
Papnicolaou Papa Smear test
|
no atypical papa smear
vaginal and oral swab sample, questionnaire, papa smear
|
vaginal and oral swab sample and questionnaire
Papnicolaou Papa Smear test
|
lichen planus
vaginal and oral swab sample, questionnaire, papa smear
|
vaginal and oral swab sample and questionnaire
Papnicolaou Papa Smear test
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
microbiome, papa smear
Time Frame: 5 years
|
Differences in microbiome and papa smear
|
5 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Niina K Hieta, MD, PhD, Specialist
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 19, 2017
Primary Completion (Estimated)
September 1, 2024
Study Completion (Estimated)
September 1, 2025
Study Registration Dates
First Submitted
September 7, 2016
First Submitted That Met QC Criteria
September 7, 2016
First Posted (Estimated)
September 13, 2016
Study Record Updates
Last Update Posted (Actual)
December 26, 2023
Last Update Submitted That Met QC Criteria
December 22, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- T146/2016
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on vaginal and oral swab sample, questionnaire
-
University Hospitals Cleveland Medical CenterRecruiting
-
GlaxoSmithKlineCompletedCytomegalovirus Infections | Infections, CytomegalovirusBelgium
-
Erasmus Medical CenterRecruitingPolycystic Ovary SyndromeNetherlands
-
GlaxoSmithKlineCompleted
-
Queen Mary University of LondonCompleted
-
Centre Hospitalier Universitaire de Saint EtienneNot yet recruiting
-
International Vaccine InstituteLondon School of Hygiene and Tropical Medicine; Karolinska Institutet; Centers...Not yet recruitingHPV InfectionZambia, Bangladesh, Congo, The Democratic Republic of the, Ghana, Nepal, Pakistan, Sierra Leone, Tanzania
-
Radboud University Medical CenterUnknown
-
Mỹ Đức HospitalNot yet recruitingVaginal Microbiome | Recurrent Pregnancy Loss, Not Pregnant
-
St. Jude Children's Research HospitalDepartment of Health and Human Services; Human LinkCompleted